Please use this identifier to cite or link to this item:
https://doi.org/10.1186/s12885-015-1191-3
| Title: | Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status | Authors: | Chong, Dawn qingqing Toh, Xinyi Ho, Ivyaw Sia, Kianchuan Newman, Jennifer P. Yulyana, Yulyana Ng, Waihoe Lai, Sianghui Ho, Mac M F Dinesh, Nivedh Tham, Cheekian Lam, Yeng Po Paula |
Issue Date: | 2015 | Publisher: | BioMed Central | Citation: | Chong, Dawn qingqing, Toh, Xinyi, Ho, Ivyaw, Sia, Kianchuan, Newman, Jennifer P., Yulyana, Yulyana, Ng, Waihoe, Lai, Sianghui, Ho, Mac M F, Dinesh, Nivedh, Tham, Cheekian, Lam, Yeng Po Paula (2015). Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status. BMC Cancer 15 (1). ScholarBank@NUS Repository. https://doi.org/10.1186/s12885-015-1191-3 | Source Title: | BMC Cancer | URI: | http://scholarbank.nus.edu.sg/handle/10635/127278 | ISSN: | 14712407 | DOI: | 10.1186/s12885-015-1191-3 |
| Appears in Collections: | Staff Publications |
Show full item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.